Literature DB >> 27730445

HIV and Bone Complications: Understudied Populations and New Management Strategies.

Michael T Yin1, Todd T Brown2.   

Abstract

The higher risk of osteoporosis and fracture associated with HIV infection and certain antiretrovirals has been well established and the need for risk stratification among older adults increasingly recognized. This review focuses upon emerging data on bone complications with HIV/HCV coinfection, in children and adolescents, and with pre-exposure prophylaxis (PrEP), as well as new management strategies to minimize the negative effects of ART on bone.

Entities:  

Keywords:  Bone; Bone loss; Bone mineral density; Children and adolescents; Fracture; HIV/HCV coinfection; Osteoporosis; Peak bone mass; PrEP; Tenofovir

Mesh：

Year:  2016        PMID： 27730445     DOI： 10.1007/s11904-016-0341-9

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN： 1548-3568            Impact factor:   5.071


  79 in total

1.  Antiretroviral therapy and bone mineral measurements in HIV-infected youths.

Authors:  Gianvincenzo Zuccotti; Alessandra Viganò; Clara Gabiano; Vania Giacomet; Federica Mignone; Sara Stucchi; Valeria Manfredini; Francesca Marinacci; Stefano Mora
Journal:  Bone       Date:  2010-03-06       Impact factor: 4.398

2.  Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.

Authors:  Todd T Brown; Carlee Moser; Judith S Currier; Heather J Ribaudo; Jennifer Rothenberg; Theodoros Kelesidis; Otto Yang; Michael P Dubé; Robert L Murphy; James H Stein; Grace A McComsey
Journal:  J Infect Dis       Date:  2015-05-05       Impact factor: 5.226

3.  In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers.

Authors:  Alessandra Viganò; Stefano Mora; Vania Giacomet; Sara Stucchi; Valeria Manfredini; Clara Gabiano; Filippo Salvini; Monica Cellini; Enrica Tamburrini; Maria Puzzovio; Gian Vincenzo Zuccotti
Journal:  Antivir Ther       Date:  2011

4.  Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

Authors:  Jürgen K Rockstroh; Amanda Mocroft; Vincent Soriano; Cristina Tural; Marcello H Losso; Andrzej Horban; Ole Kirk; Andrew Phillips; Bruno Ledergerber; Jens Lundgren
Journal:  J Infect Dis       Date:  2005-08-11       Impact factor: 5.226

Review 5.  Do people with HIV infection have a higher risk of fracture compared with those without HIV infection?

Authors:  Jennifer Hoy; Benjamin Young
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

6.  Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children.

Authors:  Babette S Zemel; Mary B Leonard; Andrea Kelly; Joan M Lappe; Vicente Gilsanz; Sharon Oberfield; Soroosh Mahboubi; John A Shepherd; Thomas N Hangartner; Margaret M Frederick; Karen K Winer; Heidi J Kalkwarf
Journal:  J Clin Endocrinol Metab       Date:  2010-01-26       Impact factor: 5.958

7.  Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.

Authors:  Denise L Jacobson; Jane C Lindsey; Catherine M Gordon; Jack Moye; Dana S Hardin; Kathleen Mulligan; Grace M Aldrovandi
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

8.  Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.

Authors:  Brenda G Mirembe; Clifton W Kelly; Nyaradzo Mgodi; Susan Greenspan; James Y Dai; Ashley Mayo; Jeanna Piper; Carolyne A Akello; Flavia M Kiweewa; Tsitsi Magure; Clemensia Nakabiito; Jeanne M Marrazzo; Z Mike Chirenje; Sharon A Riddler
Journal:  J Acquir Immune Defic Syndr       Date:  2016-03-01       Impact factor: 3.731

9.  Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults.

Authors:  Joel Gallant; Jason Brunetta; Gordon Crofoot; Paul Benson; Anthony Mills; Cynthia Brinson; Shinichi Oka; Andrew Cheng; Will Garner; Marshall Fordyce; Moupali Das; Scott McCallister
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

10.  Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.

Authors:  Anthony Mills; Jose R Arribas; Jaime Andrade-Villanueva; Giovanni DiPerri; Jan Van Lunzen; Ellen Koenig; Richard Elion; Matthias Cavassini; Jose Valdez Madruga; Jason Brunetta; David Shamblaw; Edwin DeJesus; Chloe Orkin; David A Wohl; Indira Brar; Jeffrey L Stephens; Pierre-Marie Girard; Gregory Huhn; Andrew Plummer; Ya-Pei Liu; Andrew K Cheng; Scott McCallister
Journal:  Lancet Infect Dis       Date:  2015-11-02       Impact factor: 25.071
View more
  15 in total

1.  Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.

Authors:  Matthew A Spinelli; David V Glidden; Peter L Anderson; Monica Gandhi; Vanessa M McMahan; Patricia Defechereux; Mauro Schechter; Valdiléa G Veloso; Suwat Chariyalertsak; Juan V Guanira; Linda-Gail Bekker; Susan P Buchbinder; Robert M Grant
Journal:  AIDS Res Hum Retroviruses       Date:  2019-06-19       Impact factor: 2.205

2.  Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared With Men.

Authors:  Kristine M Erlandson; Jordan E Lake; Myung Sim; Julian Falutz; Carla M Prado; Ana Rita Domingues da Silva; Todd T Brown; Giovanni Guaraldi
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

Review 3.  HIV preexposure prophylaxis for adolescents and young adults.

Authors:  Emily Allen; Allegra Gordon; Douglas Krakower; Katherine Hsu
Journal:  Curr Opin Pediatr       Date:  2017-08       Impact factor: 2.856

4.  Geriatric conditions and healthcare utilisation in older adults living with HIV.

Authors:  Meredith Greene; Ying Shi; John Boscardin; Rebecca Sudore; Monica Gandhi; Kenneth Covinsky
Journal:  Age Ageing       Date:  2022-05-01       Impact factor: 12.782

5.  Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK.

Authors:  Sean J Iwamoto; Micol S Rothman; Shenghui Duan; Jonathan C Baker; Steven Mumm; Michael P Whyte
Journal:  Bone       Date:  2020-01-08       Impact factor: 4.398

Review 6.  Bone Health in People Living With HIV: The Role of Exercise and Directions for Future Research.

Authors:  Joseph D Perazzo; Allison R Webel; Carl J Fichtenbaum; Grace A McComsey
Journal:  J Assoc Nurses AIDS Care       Date:  2017-10-04       Impact factor: 1.809

7.  Decreased bone turnover in HIV-infected children on antiretroviral therapy.

Authors:  Stephanie Shiau; Michael T Yin; Renate Strehlau; Faeezah Patel; Ndileka Mbete; Louise Kuhn; Ashraf Coovadia; Stephen M Arpadi
Journal:  Arch Osteoporos       Date:  2018-04-05       Impact factor: 2.617

8.  Cost-effective osteoporosis treatment thresholds for people living with HIV infection in Greece.

Authors:  P Makras; N Boubouchairopoulou; I Katsarolis; K Athanasakis
Journal:  J Musculoskelet Neuronal Interact       Date:  2017-12-01       Impact factor: 2.041

9.  Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study.

Authors:  Cornelia Bayard; Bruno Ledergerber; Markus Flepp; Thanh Lecompte; Estelle Moulin; Matthias Hoffmann; Rainer Weber; Cornelia Staehelin; Caroline Di Benedetto; Christoph A Fux; Philip E Tarr; Barbara Hasse
Journal:  Open Forum Infect Dis       Date:  2017-08-22       Impact factor: 3.835

10.  Mexican patients with HIV have a high prevalence of vertebral fractures.

Authors:  José Antonio Mata-Marín; Carla I Arroyo-Anduiza; María de Los Ángeles Berrospe-Silva; Alberto Chaparro-Sánchez; Ana Gil-Avila; Jesús Gaytán-Martínez
Journal:  Infect Dis Rep       Date:  2018-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.